Category: News

Empowering investors with access to the best research, experts and opportunities.

News

How the data industry will grow despite new regulations

Less than a quarter of consumers trust big tech companies like Facebook and Google with their data, and 77 percent want stricter rules governing the way their information is collected and used. But even consumers’ uneasy relationship to businesses collecting their personal information hasn’t hampered the growth of the global data analytics industry, which is tipped to grow from its current value of roughly USD $190 billion up to USD $274 billion by 2022.

Read more

Technology executives scrambling after US Senate roasting

Executives from the world’s largest (and most valuable) tech companies were hauled before the US senate last week to defend their companies’ content moderation policies as regulators look to crack down on poor conduct.

Read more

UK government weighs up nuclear power options

Uranium has long been a controversial material, but recent changes on the supply and demand sides, and a growing demand for reliable, low-emitting power generation makes the other yellow metal very hot property, according to Arnott Capital portfolio manager Kenny Arnott. Speaking at Reach Markets’ Meet the Fund Manager webcast last week, Mr Arnott said “Uranium represents a promising, asymmetric investment opportunity”.

Read more

The markets and the US Election

The markets’ behaviour heading into the election is historically very volatile, as the markets try to price in the different parties policies and how they will affect industry.

Read more

US election gives traders opportunity to make portfolios great again

The fifth session took a fresh look at the biggest news of the week – Democratic Party nominee Joe Biden ousting incumbent US President Donald Trump from the White House, and what the changing American political landscape means for traders.

Read more

Rural Funds Group: Diversifying is the key to Australian agri investment

Agriculture is a popular way for investors to diversify their portfolios. Agricultural investments in Australia, however, come with the risks of our sunburnt country.

Read more

Is “next-gen” CAR-T the beginning of the end of cancer?

Cancer is a word we all dread to hear yet a cure for the deadly disease has always felt so far away. However, thanks to huge strides made in cancer treatments, some industry experts believe that we can finally strive towards curative intent.

Read more

The Uranium Industry Report: New clear direction for nuclear power

Nuclear energy has reemerged as a potential winner in the race to supply clean base-load energy after Democratic nominee and pro-nuclear power Joe Biden won a tumultuous US Presidential election. Investors will likely look to uranium, the nuclear feedstock, as...

Read more

Special Research Report: How a 20-year tech veteran’s restructure could see its value double

Four-fifths of all business revenue growth is expected to come from digital offerings and operations over the next three years, making data absolutely critical to businesses worldwide. Already valued at US$190 billion2 in 2019, the data analytics industry is forecast…

Read more

The asymmetric benefits of investing in nuclear power

Uranium has long been a controversial material, but recent changes on the supply and demand sides, and a growing demand for reliable, low-emitting power generation makes the other yellow metal very hot property, according to Arnott Capital portfolio manager Kenny Arnott. Speaking at Reach Markets’ Meet the Fund Manager webcast last week, Mr Arnott said “Uranium represents a promising, asymmetric investment opportunity”.

Read more

Amplia’s promising cancer and fibrosis drug enters clinical trials

Solid tumours are notoriously difficult to treat. A recently discovered cancer protein could be the reason why. The protein, known as Focal Adhesion Kinase (FAK), acts as a tumour’s defense mechanism. It hinders the effects of chemotherapy and shields the cancer from the body’s immune system. It also plays an important role in tumours’ ability to spread.

Read more

Prescient Therapeutics – Interview with Dr Allen Ebens

In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a shining light on the horizon.

Read more

Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency

Receive the latest news and media directly to your inbox

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.